Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
11m
J&J : DARZALEX FASPRO Quadruplet Regimen Improves MRD Negativity In Newly Diagnosed Multiple Myeloma
Johnson & Johnson (JNJ) announced results from the Phase 3 CEPHEUS study demonstrating a significant clinical improvement with ...
59m
J&J : Phase 3 Trial Results Show CARVYKTI Extends Overall Survival In Relapsed Multiple Myeloma
Janssen-Cilag International NV, a Johnson & Johnson company, announced three-year follow-up data from the Phase 3 CARTITUDE-4 study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
'Harry Potter' star dies
Helene: How to help
High-end brothel plea
Troops to leave some bases
Promotes watch collection
ICE: Convicts roaming free
Congressional Gold Medal
NC dam failure ‘imminent’
World's oldest cheese found
Ending password-sharing
Boxes to distribute Narcan
Producing doc on Diddy
50/50 ball ownership suit
Urgent safety alert for 737s
Killer gets life sentence
ISR targets Hezbollah HQ
Meta hit with privacy fine
Bill to use birth control
US charges three Iranians
Fed inflation gauge cools
Van Gogh paintings attacked
Fake Biden robocalls fine
Pleads not guilty
Diocese reaches settlement
KY sues Express Scripts
NY ballot appeal rejected
Deposition in AI suit
Dow closes at record high
Feedback